Abcl stock forecast.

Flood threats remain in parts of the NSW south-east hammered by a severe weather system now moving into Victoria, where days of heavy rain is expected.ABCL stock's Price/Earning ratio is 12.33. Our analysis grades ABCL stock's Price / Earning ratio at F. This means that ABCL stock's Price/Earning ratio is above 62% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ABCL may be a overvalued for its sector.ABCL Stock Analysis: Impressive Performance and Optimistic Analyst Forecasts ABCL stock had an impressive performance on September 20, 2023, based on the information provided. The 7 analysts offering 12-month price forecasts for Abcellera Biologics Inc have a median target of 28.00, with a high estimate of 34.00 and a low estimate of 12.00.Price Performance Review of ABCL. On Monday, AbCellera Biologics Inc [NASDAQ:ABCL] saw its stock fall -4.79% to $4.47. On the same session, the stock had its day’s lowest price of $4.44, but rose to a high of $4.78. Over the last five days, the stock has gained 10.77%. AbCellera Biologics Inc shares have fallen nearly -55.82% since the year ...

According to data from CNN Money, the 8 analysts offering 12-month price forecasts for ABCL had a median target of $24.50, with a high estimate of $34.00 and a low estimate of $12.00. This median estimate represents a remarkable increase of +517.13% from the stock’s last price of $3.97.Stock Price Forecast. According to 10 stock analysts, the average 12-month stock price forecast for NIO Inc. stock is $12.44, which predicts an increase of 73.99%. The lowest target is $8.00 and the highest is $18. On average, analysts rate NIO Inc. stock as a buy. Analyst Consensus: Buy. Target Low Average Median

Insiders purchased significant amount of AbCellera stock directly after Q1. See why I ABCL shares are increasingly attractive for long-term, patient investors.Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -618.82% from its current level, while the stock would need to crash -111.42% from its current level to reach the projected low.

ABCL Stock Forecast - Is ABCL a buy or sell? Find out now with a free analysis on AbCellera Biologics. Should I buy or sell ABCL? ABCL Stock Analysis - [Full Report] ABCL Chart by TradingView. Antibodies Stocks Antibody Stocks Biologics Stocks Database Stocks Drug Stocks Immune Stocks Natural StocksFind real-time AB - AllianceBernstein Holding LP stock quotes, company profile, news and forecasts from CNN Business.Insiders purchased significant amount of AbCellera stock directly after Q1. See why I ABCL shares are increasingly attractive for long-term, patient investors.Over the past year, ABCL has underperformed the S&P 500, with a price decline of 28.37% against the S&P 500's growth of 17.07%. Data by YCharts. ABCL's market cap stands at $2.07B, with total debt ...Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. AbCellera Biologics stock news, updates & related news. Find out why AbCellera Biologics's (ABCL) news sentiment is 14.35% more negative in relation to stocks in the Healthcare sector.

The average stock forecast for Abcellera Biologics Inc (ABCL) is 22.44 USD. This price target corresponds to an upside of 364.60%. The range of stock forecasts for ABCL is …

19 sept 2023 ... ... (ABCL) Stock's Price and Volume. The market has been down on AbCellera Biologics Inc (ABCL) stock recently. ABCL gets a Bearish score from ...

As a result, it might be a surprise to see that the analysts have cut their price target 10% to US$30.00, which could suggest the forecast improvement in performance is not expected to last.Earnings announcement* for ABC: May 02, 2023. AmerisourceBergen Corporation (Holding Co) is expected* to report earnings on 05/02/2023 before market open. The report will be for the fiscal Quarter ...7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.2,065.00 -2.10(-0.10%) AbCellera Biologics Inc. (ABCL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.7800 +0.0500 (+1.06%) At close: 04:00PM EST 4.7600 -0.02 (-0.42%)... Stock Price Forecast. According to 14 stock analysts, the average 12-month stock price forecast for Palantir stock is $13.25, which predicts a decrease of -34.63%. The lowest target is $5.00 and the highest is $25. On average, analysts rate …ABCL stock recorded 16/30 (53%) green days with 5.07% price volatility over the last 30 days. Based on our AbCellera Biologics stock forecast, it's now a bad time to buy ABCL stock because it's trading 6.53% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comTipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comMay 4, 2023 · AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.54 per share a year ago. According to 16 stock analysts, the average 12-month stock price forecast for SOFI stock stock is $8.78, which predicts an increase of 12.13%. The lowest target is $3.00 and the highest is $15. On average, analysts rate SOFI stock stock as a hold.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comABCL Stock Performance: A Look at May 26, 2023. On May 26, 2023, Abcellera Biologics Inc (ABCL) saw a significant increase in its stock price, with shares trading at $28.00, up 306.39% from the previous day’s closing price. This surge in price can be attributed to the positive outlook of the 9 analysts who offer 12-month price forecasts …

5 abr 2023 ... Their average price target stands at $19, implying 266% upside potential. AbCellera Biologics (ABCL). Pipette adding fluid to one of several ...About the AbCellera Biologics Inc stock forecast. As of 2023 November 28, Tuesday current price of ABCL stock is 4.530$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. AbCellera Biologics stock price has been showing a declining tendency so we believe that similar …

Analyst Future Growth Forecasts. Earnings vs Savings Rate: ABC's forecast earnings growth (7.2% per year) is above the savings rate (2.1%). Earnings vs Market: ABC's earnings (7.2% per year) are forecast to grow slower than the Australian market (9.1% per year). High Growth Earnings: ABC's earnings are forecast to grow, but not …ABCL stock's Price/Earning ratio is 12.33. Our analysis grades ABCL stock's Price / Earning ratio at F. This means that ABCL stock's Price/Earning ratio is above 62% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ABCL may be a overvalued for its sector.Recursion Pharmaceuticals Inc. 6.87. -0.18. -2.55%. Get Abcellera Biologics Inc (ABCL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.The current average ABCL price target, as estimated by these analysts, is $27.75. The predictions for the future ABCL stock price range from a low of $18.00 to a high of $34.00 , highlighting the variability of market expectations for ABCL .At the close of trading, the stock’s price was $4.50, to imply an increase of 1.58% or $0.07 in intraday trading. The ABCL share’s 52-week high remains $14.15, putting it -214.44% down since that peak but still an impressive 14.0% since price per share fell to its 52-week low of $3.87.2 days ago · Stock Price Forecast. According to 7 stock analysts, the average 12-month stock price forecast for ABCL stock stock is $23.29, which predicts an increase of 436.64%. The lowest target is $12 and the highest is $32. On average, analysts rate ABCL stock stock as a strong buy. ABCL | Complete AbCellera Biologics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Ownership SEC Filings Short Interest Social Media ABCL vs. SMMT, MRUS, RYZB, ARVN, IRON, AMRX, MRVI, MIRM, PCRX, and PNT

View the ABCL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abcellera Biologics Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view …

Track AbCellera Biologics Inc (ABCL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Recursion Pharmaceuticals Inc. 6.87. -0.18. -2.55%. Get Abcellera Biologics Inc (ABCL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.AbCellera Biologics Inc. research and ratings by Barron's. View ABCL revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Based on short-term price targets offered by eight analysts, the average price target for AbCellera Biologics Inc. comes to $20.75. The forecasts range from a low of $10.00 to a high of $32.00.AbCellera Biologics Inc. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: ABCL | NasdaqTrack AbCellera Biologics Inc (ABCL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBeing prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...AbCellera (Nasdaq: ABCL) today presented new data on its T-cell engager (TCE) platform in two poster presentations at the American Society for Cancer Research (AACR) Annual Meeting 2023, which is being... ABCL : 4.18 (-5.00%) 1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy Motley Fool - Thu Apr 13, 4:50AM CDT.What this means: InvestorsObserver gives AbCellera Biologics Inc (ABCL) an overall rank of 36, which is below average. AbCellera Biologics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 36 means that 64% of stocks appear more favorable to our system.ABCL | Complete AbCellera Biologics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.

We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...ABCL Earnings Date and Information. AbCellera Biologics last issued its quarterly earnings data on November 2nd, 2023. The reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.04. The business earned $6.60 million during the quarter, compared to the consensus estimate of $11.92 million.Nov 27, 2023 · Get the latest information on AbCellera Biologics Inc. (ABCL), a biotechnology company that discovers antibodies from natural immune responses. See its stock price, earnings, revenue, financial statements, analyst forecasts, news and more. ABCL: AbCellera Biologics - Price and Consensus Chart. Get the latest Price and Consensus Chart for AbCellera Biologics from Zacks Investment ResearchInstagram:https://instagram. bond brokeragereit to invest in 2023top a i stocksforrester research stock Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.AbCellera Biologics Stock Forecast. Is AbCellera Biologics Stock Undervalued? The current AbCellera Biologics [ ABCL] share price is $4.47. The Score for ABCL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. ABCL is currently trading in the 40-50% percentile range relative to its historical Stock ... amg gt 43 horsepowerelon musk jobs Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.AbCellera Biologics saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 27,470,000 shares, a drop of 1.2% from the previous total of 27,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting ... penny stock dividends Inflation hits lowest level since 2021, Fed's preferred gauge shows. Find the latest AbCellera Biologics Inc. (ABCL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight ... The Bilibili Inc. stock forecast for tomorrow is $ 11.34, which would represent a 0.50% gain compared to the current price. In the next week, the price of BILI is expected to decrease by -8.68% and hit $ 10.31. As far as the long-term Bilibili Inc. stock forecast is concerned, here’s what our predictions are currently suggesting. Abcellera Biologics earnings beat by $0.11, revenue fell short of estimates. By Investing.com. • Aug 03, 2023. Investing.com - Abcellera Biologics (NASDAQ: ABCL) reported second quarter EPS of ...